Icon

SEEBRI (nda207923)- (15.6MCG/INH)

GLYCOPYRROLATE NOVARTIS
15.6MCG/INH
No No
2028-Oct-20 Expired
None 2018-Oct-29
None No
SEEBRI NEOHALER is an anticholinergic indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
0 0 0
Total Other Developers 1
Drugs with Suitability No
15.6MCG/INH ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.